Anti-GPX1 monoclonal antibody

Pre-made anti-GPX1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPX1/GPX1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T70654-Ab-1/ GM-Tg-hg-T70654-Ab-2Anti-Human GPX1 monoclonal antibodyHuman
GM-Tg-rg-T70654-Ab-1/ GM-Tg-rg-T70654-Ab-2Anti-Rat GPX1 monoclonal antibodyRat
GM-Tg-mg-T70654-Ab-1/ GM-Tg-mg-T70654-Ab-2Anti-Mouse GPX1 monoclonal antibodyMouse
GM-Tg-cynog-T70654-Ab-1/ GM-Tg-cynog-T70654-Ab-2Anti-Cynomolgus/ Rhesus macaque GPX1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T70654-Ab-1/ GM-Tg-felg-T70654-Ab-2Anti-Feline GPX1 monoclonal antibodyFeline
GM-Tg-cang-T70654-Ab-1/ GM-Tg-cang-T70654-Ab-2Anti-Canine GPX1 monoclonal antibodyCanine
GM-Tg-bovg-T70654-Ab-1/ GM-Tg-bovg-T70654-Ab-2Anti-Bovine GPX1 monoclonal antibodyBovine
GM-Tg-equg-T70654-Ab-1/ GM-Tg-equg-T70654-Ab-2Anti-Equine GPX1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T70654-Ab-1/ GM-Tg-hg-T70654-Ab-2; GM-Tg-rg-T70654-Ab-1/ GM-Tg-rg-T70654-Ab-2;
GM-Tg-mg-T70654-Ab-1/ GM-Tg-mg-T70654-Ab-2; GM-Tg-cynog-T70654-Ab-1/ GM-Tg-cynog-T70654-Ab-2;
GM-Tg-felg-T70654-Ab-1/ GM-Tg-felg-T70654-Ab-2; GM-Tg-cang-T70654-Ab-1/ GM-Tg-cang-T70654-Ab-2;
GM-Tg-bovg-T70654-Ab-1/ GM-Tg-bovg-T70654-Ab-2; GM-Tg-equg-T70654-Ab-1/ GM-Tg-equg-T70654-Ab-2
Products NameAnti-GPX1 monoclonal antibody
Formatmab
Target NameGPX1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPX1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T70654-Ag-1Recombinant multi-species GPX1/ GPXD/ GSHPX1 protein
    ORF Viral VectorvGMAD000015human GPX1 Adenovirus particle
    ORF Viral VectorpGMAD000015human GPX1 Adenovirus plasmid
    ORF Viral VectorpGMAD000415human GPX1 Adenovirus plasmid
    ORF Viral VectorvGMAD000415human GPX1 Adenovirus particle
    ORF Viral VectorpGMLPm002579mouse Gpx1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002579mouse Gpx1 Lentivirus particle


    Target information

    Target IDGM-T70654
    Target NameGPX1
    Gene ID2876,14775,24404,706732,442961,101083751,281209,100053396
    Gene Symbol and SynonymsCGPx,Gpx,GPx-1,GPX1,GPXD,GSHPx,GSHPx-1,GSHPX1
    Uniprot AccessionP07203,P04041,P00435
    Uniprot Entry NameGPX1_HUMAN,GPX1_RAT,GPX1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseLung Cancer
    Gene EnsemblENSG00000233276
    Target ClassificationN/A

    The target: GPX1, gene name: GPX1, also named as GPXD, GSHPX1. The protein encoded by this gene belongs to the glutathione peroxidase family, members of which catalyze the reduction of organic hydroperoxides and hydrogen peroxide (H2O2) by glutathione, and thereby protect cells against oxidative damage. Other studies indicate that H2O2 is also essential for growth-factor mediated signal transduction, mitochondrial function, and maintenance of thiol redox-balance; therefore, by limiting H2O2 accumulation, glutathione peroxidases are also involved in modulating these processes. Several isozymes of this gene family exist in vertebrates, which vary in cellular location and substrate specificity. This isozyme is the most abundant, is ubiquitously expressed and localized in the cytoplasm, and whose preferred substrate is hydrogen peroxide. It is also a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. This gene contains an in-frame GCG trinucleotide repeat in the coding region, and three alleles with 4, 5 or 6 repeats have been found in the human population. The allele with 4 GCG repeats has been significantly associated with breast cancer risk in premenopausal women. Alternatively spliced transcript variants have been found for this gene. Pseudogenes of this locus have been identified on chromosomes X and 21. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.